In order for our site to display correctly you will need a newer version of your web browser.

Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.

The default player for embedding or displaying video on stjude.org. Default size: 480x270

Acute Lymphoblastic Leukemia: Erasing the Survival Gap

Acute lymphoblastic leukemia (ALL), a disease of the blood, is the most common childhood cancer. When St. Jude Children’s Research Hospital opened its doors in 1962, childhood ALL had a survival rate of only 4 percent. Treatment approaches developed at St. Jude have revolutionized the way this cancer is treated. Today, nine out of 10 ALL patients at St. Jude become long-term survivors.

National statistics show that African-American and Hispanic children with ALL are less likely than white children to survive their disease. But at St. Jude, patients of all races and ethnic backgrounds share the same high rates of survival.

Precise treatment plans, tailored to each child, are only one of the reasons St. Jude has been successful at erasing the survival gap. No family ever receives a bill from St. Jude for treatment or associated costs, giving families better access to care. Also important is the extensive care team focused on each patient and family throughout their cancer journey.

This video was created in a community partnership between St. Jude and the Pink Palace Family of Museums in Memphis, Tennessee.